{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:03:17Z","timestamp":1793858597902,"version":"4.6.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001862","name":"Swedish Research Council Formas","doi-asserted-by":"publisher","award":["2020-02696"],"award-info":[{"award-number":["2020-02696"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["43301"],"award-info":[{"award-number":["43301"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.nbd.2021.105429","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:55:18Z","timestamp":1624064118000},"page":"105429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism"],"prefix":"10.1016","volume":"157","author":[{"given":"Laura","family":"Andreoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Abbaszadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105429_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0015","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.0837-12.2012","article-title":"Galpha(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"32","author":"Alcacer","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI90132","article-title":"Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson\u2019s disease therapy","volume":"127","author":"Alcacer","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2021.105429_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNF.0000000000000285","article-title":"Postural disorders and antiparkinsonian treatments in Parkinson disease: an exploratory case-control study","volume":"41","author":"Ameghino","year":"2018","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.nbd.2021.105429_bb0030","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","article-title":"Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors","volume":"32","author":"Anzalone","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(93)90840-E","article-title":"Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression","volume":"235","author":"Asin","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105429_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1254\/jphs.12214FP","article-title":"Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine","volume":"121","author":"Babovic","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2021.105429_bb0050","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1523\/JNEUROSCI.2664-12.2012","article-title":"Rebalance of striatal NMDA\/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson\u2019s disease","volume":"32","author":"Bagetta","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","article-title":"Dystonia","volume":"4","author":"Balint","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.nbd.2021.105429_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.08.014","article-title":"Morphine-induced Straub tail reaction in mice treated with serotonergic compounds","volume":"791","author":"Belozertseva","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105429_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2021.105429_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.1960.tb00277.x","article-title":"The anatomical basis of the straub phenomenon","volume":"15","author":"Bilbey","year":"1960","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.nbd.2021.105429_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088121","article-title":"Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia","volume":"9","author":"Black","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105429_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bihy.2008.01.006","article-title":"New hypotheses about postural control support the notion that all dystonias are manifestations of excessive brain postural function","volume":"1","author":"Blood","year":"2008","journal-title":"Biosci Hypotheses"},{"key":"10.1016\/j.nbd.2021.105429_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.870050103","article-title":"Induction of chorea and dystonia in parkinsonian primates","volume":"5","author":"Boyce","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0090","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.40.6.927","article-title":"Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson\u2019s disease","volume":"40","author":"Boyce","year":"1990","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2021.105429_bb0095","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00508-006-0737-4","article-title":"Imaging the role of dopamine in health and disease Parkinson\u2019s disease as a lesion model","volume":"118","author":"Brooks","year":"2006","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.nbd.2021.105429_bb0100","doi-asserted-by":"crossref","first-page":"104579","DOI":"10.1016\/j.nbd.2019.104579","article-title":"Dystonia and levodopa-induced dyskinesias in Parkinson\u2019s disease: is there a connection?","volume":"132","author":"Calabresi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105429_bb0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00415-009-0072-6","article-title":"Reversible Pisa syndrome in patients with Parkinson\u2019s disease on dopaminergic therapy","volume":"256","author":"Cannas","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/syn.20527","article-title":"Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat","volume":"62","author":"Carta","year":"2008","journal-title":"Synapse."},{"key":"10.1016\/j.nbd.2021.105429_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fneur.2014.00242","article-title":"Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications","volume":"5","author":"Cenci","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2174\/187152711797247885","article-title":"Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson\u2019s disease","volume":"10","author":"Cenci","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2021.105429_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00702-018-1886-0","article-title":"On the neuronal circuitry mediating L-DOPA-induced dyskinesia","volume":"125","author":"Cenci","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2021.105429_bb0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.27959","article-title":"Dyskinesia matters","volume":"35","author":"Cenci","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0766-3","article-title":"Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists","volume":"193","author":"Collins","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2021.105429_bb0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/acschemneuro.5b00020","article-title":"Identification of G protein-biased agonists that fail to recruit beta-arrestin or promote internalization of the D1 dopamine receptor","volume":"6","author":"Conroy","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/NDT.S2325","article-title":"Update on the use of pramipexole in the treatment of Parkinson\u2019s disease","volume":"4","author":"Constantinescu","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2021.105429_bb0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105429_bb0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000480624","article-title":"Priming as a model of behavioural sensitization","volume":"18","author":"Di Chiara","year":"1992","journal-title":"Dev. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2021.105429_bb0160","article-title":"The spectrum of levodopa-induced dyskinesias","volume":"47","author":"Fahn","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0165","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/mds.25133","article-title":"A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating Scale","volume":"27","author":"Fox","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2011.01.024","article-title":"Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease","volume":"42","author":"Francardo","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2021.105429_bb0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2020.09.027","article-title":"Why target brain adenosine receptors? A historical perspective","volume":"80","author":"Fredholm","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0180","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1523\/JNEUROSCI.4859-09.2010","article-title":"Bilateral postsynaptic actions of pyramidal tract and reticulospinal neurons on feline erector spinae motoneurons","volume":"30","author":"Galea","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00429-012-0405-6","article-title":"Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum","volume":"218","author":"Gangarossa","year":"2013","journal-title":"Brain Struct. Funct."},{"issue":"787\u2013795","key":"10.1016\/j.nbd.2021.105429_bb0195","article-title":"A subpopulation of striatal neurons mediates levodopa-induced dyskinesia","volume":"97","author":"Girasole","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105429_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuron.2014.11.024","article-title":"Distinct limb and trunk premotor circuits establish laterality in the spinal cord","volume":"85","author":"Goetz","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105429_bb0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-4886(92)90125-A","article-title":"Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys","volume":"117","author":"Gomez-Mancilla","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0","article-title":"Clinical rating of dyskinesias in Parkinson\u2019s disease: use and reliability of a new rating scale","volume":"14","author":"Hagell","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2013.09.003","article-title":"Modulating mGluR5 and 5-HT1A\/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action","volume":"250","author":"Iderberg","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2014_352","article-title":"Symptomatic models of Parkinson\u2019s disease and L-DOPA-induced dyskinesia in non-human primates","volume":"22","author":"Johnston","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0225","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105429_bb0230","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2018.06.024","article-title":"Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: implications for L-DOPA-induced dyskinesia","volume":"138","author":"Lanza","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2021.105429_bb0235","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1023\/A:1009402126770","article-title":"Embryonic dormancy phenomenon in obstructed healthy mouse fallopian tubes","volume":"17","author":"Lee","year":"2000","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.nbd.2021.105429_bb0422","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0b013e32833a5c68","article-title":"Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats","volume":"21","author":"Li","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.nbd.2021.105429_bb0240","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0245","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105429_bb0250","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S1461145712000569","article-title":"Hyperactivity induced by the dopamine D2\/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice","volume":"16","author":"Luque-Rojas","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2021.105429_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0923-2508(92)90012-D","article-title":"Identification of sulpholipid I by thin-layer chromatography in the rapid identification of Mycobacterium tuberculosis","volume":"143","author":"Luquin","year":"1992","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.nbd.2021.105429_bb0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410310514","article-title":"Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys","volume":"31","author":"Luquin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JPD-2012-120103","article-title":"Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life","volume":"2","author":"Manson","year":"2012","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2021.105429_bb0270","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","article-title":"DeepLabCut: markerless pose estimation of user-defined body parts with deep learning","volume":"21","author":"Mathis","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","article-title":"The role of dopamine in the brain - lessons learned from Parkinson's disease","volume":"190","author":"Meder","year":"2019","journal-title":"Neuroimage."},{"key":"10.1016\/j.nbd.2021.105429_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/mds.870050119","article-title":"Sulpiride-induced tardive dystonia","volume":"5","author":"Miller","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0285","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0149-7634(96)00031-0","article-title":"Dopamine\/glutamate interaction as studied by combining turning behaviour and c-Fos expression","volume":"21","author":"Morelli","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2021.105429_bb0290","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1517\/14656566.7.13.1715","article-title":"Levodopa, motor fluctuations and dyskinesia in Parkinson\u2019s disease","volume":"7","author":"Muller","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.nbd.2021.105429_bb0295","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/mds.28215","article-title":"Continuous dopaminergic stimulation as a treatment for Parkinson\u2019s disease: current status and future opportunities","volume":"35","author":"Olanow","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.parkreldis.2016.08.018","article-title":"Pramipexole-associated fixed limb dystonia in Parkinson\u2019s disease","volume":"31","author":"Pandey","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","article-title":"Diametric neural ensemble dynamics in parkinsonian and dyskinetic states","volume":"557","author":"Parker","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2021.105429_bb0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410230112","article-title":"Dystonia in Parkinson\u2019s disease: clinical and pharmacological features","volume":"23","author":"Poewe","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105429_bb0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.1717194115","article-title":"Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms","volume":"115","author":"Radl","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105429_bb0320","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/mds.20988","article-title":"Development of dyskinesias in a 5-year trial of ropinirole and L-dopa","volume":"21","author":"Rascol","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0325","doi-asserted-by":"crossref","first-page":"101678","DOI":"10.1016\/j.pneurobio.2019.101678","article-title":"Dystonia and dopamine: from phenomenology to pathophysiology","volume":"182","author":"Ribot","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105429_bb0330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00178501","article-title":"Acute dystonia induced by neuroleptic drugs","volume":"88","author":"Rupniak","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2021.105429_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.05.059","article-title":"Aberrant striatal activity in parkinsonism and levodopa-induced dyskinesia","volume":"23","author":"Ryan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2021.105429_bb0340","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0345","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2021.105429_bb0421","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2016.09.001","article-title":"Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists","volume":"96","author":"Sebastianutto","year":"2016","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.nbd.2021.105429_bb0350","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI126361","article-title":"D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson\u2019s disease","volume":"130","author":"Sebastianutto","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2021.105429_bb0355","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1172\/JCI133398","article-title":"Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine","volume":"130","author":"Shen","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.nbd.2021.105429_bb0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2013.09.021","article-title":"The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation","volume":"62","author":"Shin","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105429_bb0365","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.10588","article-title":"Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats","volume":"18","author":"Steece-Collier","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0370","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2005.04.001","article-title":"Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism","volume":"20","author":"St-Hilaire","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105429_bb0375","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1080\/14656566.2016.1219337","article-title":"Advances in dopamine receptor agonists for the treatment of Parkinson\u2019s disease","volume":"17","author":"Stocchi","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.nbd.2021.105429_bb0380","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mds.23517","article-title":"Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson\u2019s disease","volume":"26","author":"Stowe","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0385","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1523\/JNEUROSCI.3042-07.2007","article-title":"Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation","volume":"27","author":"Teper","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105429_bb0390","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02740641","article-title":"Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition","volume":"16","author":"Todd","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105429_bb0395","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mds.28385","article-title":"A gain-of-function variant in dopamine D2 receptor and progressive chorea and dystonia phenotype","volume":"36","author":"van der Weijden","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105429_bb0400","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.euroneuro.2010.02.011","article-title":"The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats","volume":"20","author":"Weber","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2021.105429_bb0405","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105429_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000480718","article-title":"Pathophysiologic basis of movement disorders","volume":"33","author":"Wichmann","year":"2018","journal-title":"Prog. Neurol. Surg."},{"key":"10.1016\/j.nbd.2021.105429_bb0415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ensci.2018.09.001","article-title":"Reversible istradefylline-induced pleurothotonus in a patient with Parkinson\u2019s disease: a case report and literature review","volume":"13","author":"Yasuda","year":"2018","journal-title":"eNeurologicalSci."},{"key":"10.1016\/j.nbd.2021.105429_bb0420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0306-3623(93)90022-P","article-title":"Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice","volume":"24","author":"Zarrindast","year":"1993","journal-title":"Gen. Pharmacol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:26:52Z","timestamp":1760851612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":85,"alternative-id":["S0969996121001789"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105429","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105429"}}